Assessing Whether ImmunityBio Inc (NASDAQ: IBRX) Is Over- Or Undervalued
ImmunityBio Inc (IBRX) concluded trading on Wednesday at a closing price of $2.99, with 11.83 million shares of worth about $35.38 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.14% during that period and on July 23, 2025 the price saw a gain […]
Are Analysts Expecting A Better 2020 For ImmunityBio Inc (IBRX)?
ImmunityBio Inc (IBRX) concluded trading on Wednesday at a closing price of $2.75, with 6.4 million shares of worth about $17.6 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.89% during that period and on July 16, 2025 the price saw a gain […]
ImmunityBio Inc (NASDAQ: IBRX): The Best-Of-Breed For Investing?
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 0.74% and -8.42% over the past three months. IBRX shares are trading -55.99% year to date (YTD), with the 12-month market performance up to 6.25% higher. […]
Set Your Sights On ImmunityBio Inc (NASDAQ: IBRX)’S Upside Potential
ImmunityBio Inc (IBRX) concluded trading on Wednesday at a closing price of $2.64, with 6.75 million shares of worth about $17.81 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.04% during that period and on July 02, 2025 the price saw a gain […]
Set Your Sights On ImmunityBio Inc (NASDAQ: IBRX)’S Upside Potential
ImmunityBio Inc (IBRX) concluded trading on Wednesday at a closing price of $2.76, with 5.25 million shares of worth about $14.49 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.37% during that period and on June 25, 2025 the price saw a loss […]
ImmunityBio Inc (IBRX): A Great Stock For Handling Current Market Conditions?
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of -2.54% and 6.97% over the past three months. IBRX shares are trading 19.92% year to date (YTD), with the 12-month market performance down to -48.49% lower. […]
Stick With ImmunityBio Inc (IBRX). The Bull Are Alive And Well
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 18.42% and 5.00% over the past three months. IBRX shares are trading 23.05% year to date (YTD), with the 12-month market performance down to -48.78% lower. […]
ImmunityBio Inc (NASDAQ: IBRX): The Best-Of-Breed For Investing?
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 5.53% and -6.32% over the past three months. IBRX shares are trading 4.30% year to date (YTD), with the 12-month market performance down to -58.41% lower. […]
An Important Check-Up On ImmunityBio Inc (NASDAQ: IBRX)
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $2.60, with 6.43 million shares of worth about $16.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.02% during that period and on May 29, 2025 the price saw a gain […]
ImmunityBio Inc (IBRX): A Great Stock For Handling Current Market Conditions?
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 18.64% and -16.42% over the past three months. IBRX shares are trading 9.38% year to date (YTD), with the 12-month market performance down to -65.43% lower. […]